FLT3 and acute myeloid leukemia: Interestingly, AML blast cells expressing FLT3-ITD insertions both at JMD and TKD1 appeared more sensitive to cytarabine treatment, suggesting a dominant effect of the JMD IS of FLT3-ITD in chemotherapy response [97].